Gainers
- Forty Seven, Inc. FTSV stock surged 61.8% to $93.82 during Monday's pre-market session. The most recent rating by Mizuho, on February 12, is at Buy, with a price target of $53.00.
- Trillium Therapeutics, Inc. TRIL shares rose 50.5% to $7.60.
- Co-Diagnostics, Inc. CODX shares moved upwards by 49.4% to $19.76. The most recent rating by HC Wainwright & Co., on February 24, is at Buy, with a price target of $4.00.
- Karyopharm Therapeutics, Inc. KPTI shares moved upwards by 48.0% to $24.19. According to the most recent rating by Wedbush, on January 17, the current rating is at Neutral.
- Biocept, Inc. BIOC stock surged 46.1% to $1.14.
- Dynatronics, Inc. DYNT shares rose 35.4% to $2.60.
- Tonix Pharmaceuticals, Inc. TNXP shares rose 32.4% to $1.43.
- Titan Pharmaceuticals, Inc. TTNP stock surged 31.9% to $0.35.
- Cocrystal Pharma, Inc. COCP stock rose 31.6% to $1.75.
- Ritter Pharmaceuticals, Inc. RTTR shares moved upwards by 26.1% to $0.87.
- Allied Healthcare Prods, Inc. AHPI stock increased by 24.1% to $29.78.
- Correvio Pharma, Inc. CORV stock surged 23.9% to $0.57. According to the most recent rating by H.C. Wainwright, on December 11, the current rating is at Neutral.
- Guardion Health Sciences, Inc. GHSI shares surged 22.8% to $0.52.
- OpGen, Inc. OPGN shares increased by 20.9% to $4.10.
- Intec Pharma, Inc. NTEC stock moved upwards by 20.5% to $0.36.
- Novan, Inc. NOVN stock moved upwards by 18.2% to $0.26. The most recent rating by H.C. Wainwright, on January 06, is at Buy, with a price target of $1.50.
- Cleveland BioLabs, Inc. CBLI shares surged 17.7% to $3.93.
- Dyadic International, Inc. DYAI stock surged 17.5% to $6.92.
- Innate Pharma, Inc. IPHA shares moved upwards by 14.9% to $7.19.
- Altimmune, Inc. ALT shares rose 13.8% to $4.21.
- CHF Solutions, Inc. CHFS shares moved upwards by 12.8% to $0.53.
- Vaxart, Inc. VXRT shares rose 11.5% to $3.20.
- Lianluo Smart, Inc. LLIT shares moved upwards by 11.2% to $0.84.
- Trinity Biotech, Inc. TRIB shares moved upwards by 9.1% to $1.56.
- IMAC Holdings, Inc. IMAC shares moved upwards by 7.1% to $1.06. According to the most recent rating by Dawson James, on January 14, the current rating is at Neutral.
Losers
- SINTX Technologies, Inc. SINT stock fell 13.4% to $0.55 during Monday's pre-market session.
- Sorrento Therapeutics, Inc. SRNE shares declined 8.3% to $1.99.
- Advaxis, Inc. ADXS shares declined 3.7% to $0.78.
- Heat Biologics, Inc. HTBX stock declined 3.0% to $0.32. The most recent rating by Maxim Group, on February 06, is at Buy, with a price target of $1.00.
- Royal Philips, Inc. PHG shares plummeted 2.4% to $41.88. The most recent rating by Bank of America, on January 13, is at Buy, with a price target of $51.00.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversTrading IdeasHealth CareHealthcare Stocks Pre-Market MoversPharmaceuticalsTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in